Your browser doesn't support javascript.
loading
Perioperative administration of recombinant activated factor VII in a Glanzmann's thrombasthenia patient with platelet refractoriness: case report.
Bisinotto, Flora Margarida Barra; Martins, Laura Bisinotto; de Camargos, Giovanini Pires; Bianco, Marcelo de Paula.
Afiliación
  • Bisinotto FMB; CET/SBA Integrado de Uberaba, Uberaba, MG, Brazil; Universidade Federal do Triângulo Mineiro (UFTM), Disciplina de Anestesiologia, Uberaba, MG, Brazil. Electronic address: florabisinotto@gmail.com.
  • Martins LB; CET/SBA Integrado de Uberaba, Uberaba, MG, Brazil; Hospital Regional Jose Alencar, Uberaba, MG, Brazil.
  • de Camargos GP; Universidade de Uberaba, Faculdade de Medicina, Uberaba, MG, Brazil.
  • Bianco MP; Universidade de Uberaba, Uberaba, MG, Brazil.
Braz J Anesthesiol ; 72(6): 823-825, 2022.
Article en En | MEDLINE | ID: mdl-34852265
ABSTRACT
Glanzmann's Trombasthenia (GT) is a genetic disorder, that develops with a tendency toward bleeding and is characterized by the absence or decrease in platelet aggregation. Surgical bleeding may be difficult to control. Platelet transfusion is the main treatment, albeit refractoriness can occur. We describe the case of a patient with GT and platelet refractoriness, who was submitted to radical prostatectomy and dental extraction. The perioperative treatment with apheresis platelet concentrate and activated recombinant factor seven allowed the procedures to be performed uneventfully. We discuss the complexity of the case and the treatment option.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trombastenia Límite: Humans / Male Idioma: En Revista: Braz J Anesthesiol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trombastenia Límite: Humans / Male Idioma: En Revista: Braz J Anesthesiol Año: 2022 Tipo del documento: Article